Endeavor Health Unveils Advanced Genetic Test for Heart Disease
EVANSTON, Ill., June 2, 2026 Researchers at Endeavor Health have developed a groundbreaking genetic screening tool designed to provide...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
EVANSTON, Ill., June 2, 2026 Researchers at Endeavor Health have developed a groundbreaking genetic screening tool designed to provide...
ENCINITAS, Calif., May 11, 2026 Vasa Therapeutics, a clinical-stage biotechnology company focused on therapies targeting cardiovascular and metabolic aging,...
MADRID & NEW YORK, January 29, 2026 — A multicenter randomized clinical trial has demonstrated that remote dielectric sensing...
